Back to Search
ALAN POLLACK, MD
MD
Ophthalmology Physician
NPI: 1629063052IndividualAccepts Medicare
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
0101225387(VA)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Class of 1996
Research & Publications (20)
Comparing computed tomography localization with daily ultrasound during image-guided radiation therapy for the treatment of prostate cancer: a prospective evaluation.
PMID 17712295·J Appl Clin Med Phys·2007
4-observational
Prostate cancer radiotherapy dose response: an update of the fox chase experience.
PMID 14767286·J Urol·2004
8-other
Hepatocyte growth factor induces MDCK cell morphogenesis without causing loss of tight junction functional integrity.
PMID 14592813·Am J Physiol Cell Physiol·2004
7-preclinical
Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x.
PMID 12655519·Cancer·2003
8-other
Impact of androgen deprivation therapy on survival in men treated with radiation for prostate cancer.
PMID 12231041·Urology·2002
6-review
Early OCT changes of neuroretinal foveal thickness after first versus repeated PDT in AMD.
PMID 18094940·Int Ophthalmol·2009
4-observational
Predictive models in external beam radiotherapy for clinically localized prostate cancer.
PMID 19544539·Cancer·2009
6-review
Developing a radiation error scoring system to monitor quality control events in a radiation oncology department.
PMID 19111271·J Am Coll Radiol·2009
8-other
Analysis of targeted mutation in DJ-1 on cellular function in primary astrocytes.
PMID 19063952·Toxicol Lett·2009
7-preclinical
Parathyroid surgery and methylene blue: a review with guidelines for safe intraoperative use.
PMID 19598213·Laryngoscope·2009
5-case
MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02.
PMID 19470936·J Clin Oncol·2009
2-rct
Prognostic value of survivin in locally advanced prostate cancer: study based on RTOG 8610.
PMID 18977097·Int J Radiat Oncol Biol Phys·2009
8-other
Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancer.
PMID 19464826·Int J Radiat Oncol Biol Phys·2009
8-other
ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate.
PMID 19386445·Int J Radiat Oncol Biol Phys·2009
6-review
Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel.
PMID 18852870·Mol Vis·2008
8-other
A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer.
PMID 18672274·Urology·2008
4-observational
Long-term follow up of antenatally diagnosed megaureters.
PMID 18631923·J Pediatr Urol·2008
4-observational
Sequence variants in HTRA1 and LOC387715/ARMS2 and phenotype and response to photodynamic therapy in neovascular age-related macular degeneration in populations from Israel.
PMID 19065273·Mol Vis·2008
8-other
Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration.
PMID 19085384·Curr Eye Res·2008
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4660 KENMORE AVE, SUITE 416
ALEXANDRIA, VA 22304 - Phone
- (703) 751-0700
Quick Facts
- NPI
- 1629063052
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile